Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1990;66:46-54

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Karwatowska-Prokopczuk, E.
Right arrow Articles by Wennmalm, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Karwatowska-Prokopczuk, E.
Right arrow Articles by Wennmalm, A.

Circulation Research, Vol 66, 46-54, Copyright © 1990 by American Heart Association


ARTICLES

Effects of endothelin on coronary flow, mechanical performance, oxygen uptake, and formation of purines and on outflow of prostacyclin in the isolated rabbit heart

E Karwatowska-Prokopczuk and A Wennmalm
Department of Clinical Physiology, University of Gothenburg, Sweden.

Endothelin is a 21-residue peptide formed during incubation of isolated porcine endothelial cells. Due to its pronounced vasoconstrictor activity, endothelin has been proposed to play a role in the regulation of vascular tone. We studied the effects of synthetic endothelin (0.1- 10 nM) on coronary flow, mechanical performance, myocardial oxygen uptake, and formation of purines, and outflow of 6-ketoprostaglandin F1 alpha (metabolite of prostacyclin) in rabbit hearts perfused with saline by the Langendorff method. Endothelin dose-dependently decreased the coronary flow, at 10 nM, by about 75%. Heart rate, ventricular contractility, myocardial oxygen uptake, and purine release were affected by endothelin no more than by a corresponding mechanical reduction of the coronary flow. In contrast, the diastolic relaxation appeared to be directly diminished by endothelin. The concentration of 6-ketoprostaglandin F1 alpha in the cardiac effluent was dose- dependently elevated by about 14 times by endothelin (10 nM) (p less than 0.001). A corresponding mechanical restriction of the coronary flow insignificantly affected the effluent concentration of 6- ketoprostaglandin F1 alpha. The calcium channel blocker nifedipine (1 microM) completely abolished the decrease in diastolic relaxation induced by endothelin and markedly counteracted the peptide-induced increase in effluent concentration of 6-ketoprostaglandin F1 alpha, but did not affect the vasoconstrictor activity. These data demonstrate that endothelin induces vasoconstriction and facilitates the outflow of prostacyclin in the rabbit heart. In addition, the peptide appears to affect diastolic relaxation in this organ.


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. F. Leite-Moreira and C. Bras-Silva
Inotropic effects of ETB receptor stimulation and their modulation by endocardial endothelium, NO, and prostaglandins
Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1194 - H1199.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. F. Leite-Moreira, C. Bras-Silva, C. A. Pedrosa, and A. A. Rocha-Sousa
ET-1 increases distensibility of acutely loaded myocardium: a novel ETA and Na+/H+ exchanger-mediated effect
Am J Physiol Heart Circ Physiol, April 1, 2003; 284(4): H1332 - H1339.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
B. Pieske, B. Beyermann, V. Breu, B. M. Loffler, K. Schlotthauer, L. S. Maier, S. Schmidt-Schweda, H. Just, and G. Hasenfuss
Functional Effects of Endothelin and Regulation of Endothelin Receptors in Isolated Human Nonfailing and Failing Myocardium
Circulation, April 13, 1999; 99(14): 1802 - 1809.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. E. Beyer, G. Slesak, T. Hovelborn, S. Kazmaier, S. Nerz, and H. M. Hoffmeister
Inotropic Effects of Endothelin-1 : Interaction With Molsidomine and With BQ 610
Hypertension, January 1, 1999; 33(1): 145 - 152.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F. Brunner and L. H. Opie
Role of Endothelin-A Receptors in Ischemic Contracture and Reperfusion Injury
Circulation, February 3, 1998; 97(4): 391 - 398.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Stangl, T. Dschietzig, M. Laule, K. Alexiou, K. D. Wernecke, and G. Baumann
Pulmonary Big Endothelin Affects Coronary Tone and Leads to Enhanced, ETA-Mediated Coronary Constriction in Early Endothelial Dysfunction
Circulation, November 4, 1997; 96(9): 3192 - 3200.
[Abstract] [Full Text]


Home page
Cardiovasc ResHome page
B. D Prendergast, P. B Anning, M. J Lewis, and A. M Shah
Regulation of left ventricular relaxation in the isolated guinea-pig heart by endogenous endothelin
Cardiovasc Res, January 1, 1997; 33(1): 131 - 138.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F. Brunner and W. R. Kukovetz
Postischemic Antiarrhythmic Effects of Angiotensin-Converting Enzyme Inhibitors: Role of Suppression of Endogenous Endothelin Secretion
Circulation, October 1, 1996; 94(7): 1752 - 1761.
[Abstract] [Full Text]


Home page
CirculationHome page
T. Hiramatsu, J. Forbess, T. Miura, S. J. Roth, M. A. Cioffi MAT, and J. E. Mayer Jr
Effects of Endothelin-1 and Endothelin-A Receptor Antagonist on Recovery After Hypothermic Cardioplegic Ischemia in Neonatal Lamb Hearts
Circulation, November 1, 1995; 92(9): 400 - 404.
[Abstract] [Full Text]